Risk factors for antibiotic resistance development in healthcare settings in China: a systematic review

Antibiotic resistance (ABR) threatens the effectiveness of infectious disease treatments and contributes to increasing global morbidity and mortality. In this study, we systematically reviewed the identified risk factors for ABR among people in the healthcare system of mainland China. Five databases...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chen, Qi (VerfasserIn) , Li, Duguang (VerfasserIn) , Beiersmann, Claudia (VerfasserIn) , Neuhann, Florian (VerfasserIn) , Moazen, Babak (VerfasserIn) , Lu, Guangyu (VerfasserIn) , Müller, Olaf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2021
In: Epidemiology and infection
Year: 2021, Jahrgang: 149, Pages: 1-10
ISSN:1469-4409
DOI:10.1017/S0950268821001254
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1017/S0950268821001254
Verlag, kostenfrei, Volltext: https://www.cambridge.org/core/journals/epidemiology-and-infection/article/risk-factors-for-antibiotic-resistance-development-in-healthcare-settings-in-china-a-systematic-review/0E2A3A7858B8314FF1127FF40D0332B1
Volltext
Verfasserangaben:Qi Chen, Duguang Li, Claudia Beiersmann, Florian Neuhann, Babak Moazen, Guangyu Lu, and Olaf Müller

MARC

LEADER 00000caa a2200000 c 4500
001 178353821X
003 DE-627
005 20230426063031.0
007 cr uuu---uuuuu
008 211223s2021 xx |||||o 00| ||eng c
024 7 |a 10.1017/S0950268821001254  |2 doi 
035 |a (DE-627)178353821X 
035 |a (DE-599)KXP178353821X 
035 |a (OCoLC)1295644332 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Chen, Qi  |d 1989-  |e VerfasserIn  |0 (DE-588)1248315359  |0 (DE-627)1783537906  |4 aut 
245 1 0 |a Risk factors for antibiotic resistance development in healthcare settings in China  |b a systematic review  |c Qi Chen, Duguang Li, Claudia Beiersmann, Florian Neuhann, Babak Moazen, Guangyu Lu, and Olaf Müller 
264 1 |c 2021 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online: 03 June 2021 
500 |a Gesehen am 23.12.2021 
520 |a Antibiotic resistance (ABR) threatens the effectiveness of infectious disease treatments and contributes to increasing global morbidity and mortality. In this study, we systematically reviewed the identified risk factors for ABR among people in the healthcare system of mainland China. Five databases were systematically searched to identify relevant articles published in either English and Chinese between 1 January 2003 and 30 June 2019. A total of 176 facility-based references were reviewed for this study, ranging across 31 provinces in mainland China and reporting information from over 50 000 patients. Four major ABR risk factor domains were identified: (1) sociodemographic factors (includes migrant status, low income and urban residence), (2) patient clinical information (includes disease status and certain laboratory results), (3) admission to healthcare settings (includes length of hospitalisation and performance of invasive procedures) and (4) drug exposure (includes current or prior antibiotic therapy). ABR constitutes an ongoing major public health challenge in China. The healthcare sector-associated risk factors was the most important aspect identified in this review and need to be addressed. Primary health care system and ABR surveillance networks need to be further strengthened to prevent and control the communicable diseases, over-prescription and overuse of antibiotics. 
700 1 |a Li, Duguang  |e VerfasserIn  |4 aut 
700 1 |a Beiersmann, Claudia  |e VerfasserIn  |0 (DE-588)1031542574  |0 (DE-627)736632476  |0 (DE-576)379022524  |4 aut 
700 1 |a Neuhann, Florian  |e VerfasserIn  |0 (DE-588)1049921046  |0 (DE-627)78288881X  |0 (DE-576)403914159  |4 aut 
700 1 |a Moazen, Babak  |e VerfasserIn  |0 (DE-588)1160312494  |0 (DE-627)1023458780  |0 (DE-576)505837269  |4 aut 
700 1 |a Lu, Guangyu  |e VerfasserIn  |4 aut 
700 1 |a Müller, Olaf  |d 1954-  |e VerfasserIn  |0 (DE-588)143910698  |0 (DE-627)655906479  |0 (DE-576)339649453  |4 aut 
773 0 8 |i Enthalten in  |t Epidemiology and infection  |d Cambridge [u.a.] : Cambridge Univ. Press, 1987  |g 149(2021), Artikel-ID e141, Seite 1-10  |h Online-Ressource  |w (DE-627)267466781  |w (DE-600)1470211-3  |w (DE-576)077087127  |x 1469-4409  |7 nnas  |a Risk factors for antibiotic resistance development in healthcare settings in China a systematic review 
773 1 8 |g volume:149  |g year:2021  |g elocationid:e141  |g pages:1-10  |g extent:10  |a Risk factors for antibiotic resistance development in healthcare settings in China a systematic review 
856 4 0 |u https://doi.org/10.1017/S0950268821001254  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.cambridge.org/core/journals/epidemiology-and-infection/article/risk-factors-for-antibiotic-resistance-development-in-healthcare-settings-in-china-a-systematic-review/0E2A3A7858B8314FF1127FF40D0332B1  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20211223 
993 |a Article 
994 |a 2021 
998 |g 143910698  |a Müller, Olaf  |m 143910698:Müller, Olaf  |d 910000  |d 912800  |d 50000  |e 910000PM143910698  |e 912800PM143910698  |e 50000PM143910698  |k 0/910000/  |k 1/910000/912800/  |k 0/50000/  |p 7  |y j 
998 |g 1160312494  |a Moazen, Babak  |m 1160312494:Moazen, Babak  |d 910000  |d 912800  |e 910000PM1160312494  |e 912800PM1160312494  |k 0/910000/  |k 1/910000/912800/  |p 5 
998 |g 1049921046  |a Neuhann, Florian  |m 1049921046:Neuhann, Florian  |d 910000  |d 912800  |e 910000PN1049921046  |e 912800PN1049921046  |k 0/910000/  |k 1/910000/912800/  |p 4 
998 |g 1031542574  |a Beiersmann, Claudia  |m 1031542574:Beiersmann, Claudia  |d 910000  |d 912800  |d 50000  |e 910000PB1031542574  |e 912800PB1031542574  |e 50000PB1031542574  |k 0/910000/  |k 1/910000/912800/  |k 0/50000/  |p 3 
998 |g 1248315359  |a Chen, Qi  |m 1248315359:Chen, Qi  |d 50000  |e 50000PC1248315359  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN178353821X  |e 4026397289 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Published online: 03 June 2021","Gesehen am 23.12.2021"],"name":{"displayForm":["Qi Chen, Duguang Li, Claudia Beiersmann, Florian Neuhann, Babak Moazen, Guangyu Lu, and Olaf Müller"]},"recId":"178353821X","origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"person":[{"display":"Chen, Qi","role":"aut","family":"Chen","given":"Qi"},{"role":"aut","display":"Li, Duguang","given":"Duguang","family":"Li"},{"family":"Beiersmann","given":"Claudia","display":"Beiersmann, Claudia","role":"aut"},{"family":"Neuhann","given":"Florian","display":"Neuhann, Florian","role":"aut"},{"role":"aut","display":"Moazen, Babak","given":"Babak","family":"Moazen"},{"display":"Lu, Guangyu","role":"aut","family":"Lu","given":"Guangyu"},{"given":"Olaf","family":"Müller","role":"aut","display":"Müller, Olaf"}],"language":["eng"],"title":[{"title":"Risk factors for antibiotic resistance development in healthcare settings in China","subtitle":"a systematic review","title_sort":"Risk factors for antibiotic resistance development in healthcare settings in China"}],"relHost":[{"id":{"eki":["267466781"],"issn":["1469-4409"],"zdb":["1470211-3"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["98.1987 -"],"part":{"year":"2021","extent":"10","volume":"149","text":"149(2021), Artikel-ID e141, Seite 1-10","pages":"1-10"},"origin":[{"dateIssuedDisp":"1987-","publisher":"Cambridge Univ. Press","publisherPlace":"Cambridge [u.a.]","dateIssuedKey":"1987"}],"recId":"267466781","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Epidemiology and infection","title_sort":"Epidemiology and infection"}],"language":["eng"],"note":["Gesehen am 02.01.2019"],"disp":"Risk factors for antibiotic resistance development in healthcare settings in China a systematic reviewEpidemiology and infection"}],"physDesc":[{"extent":"10 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1017/S0950268821001254"],"eki":["178353821X"]}} 
SRT |a CHENQILIDURISKFACTOR2021